Zobrazeno 1 - 10
of 489
pro vyhledávání: '"C. Hann"'
Autor:
Elizabeth C. Hann, Sean Overa, Marcus Harland-Dunaway, Andrés F. Narvaez, Dang N. Le, Martha L. Orozco-Cárdenas, Feng Jiao, Robert E. Jinkerson
Publikováno v:
Nature Food. 3:461-471
Artificial photosynthesis systems are proposed as an efficient alternative route to capture CO2 to produce additional food for growing global demand. Here a two-step CO2 electrolyser system was developed to produce a highly concentrated acetate strea
Autor:
Arun P. Wiita, Elliot Stieglitz, Aashish Manglik, Ansuman T. Satpathy, Byron C. Hann, Faranak Fattahi, Veronica Steri, Paul Phojanokong, Anne Deucher, Jonathan Ramirez, Kevin R. Parker, Sagar P. Bapat, Jeffrey D. Whitman, Kristie L. White, Makeba Marcoulis, Jose M. Rivera, Yu-Hsiu T. Lin, Neha Paranjape, Huimin Geng, Kamal Mandal, Matthew A. Nix
Alternative strategies are needed for patients with B-cell malignancy relapsing after CD19-targeted immunotherapy. Here, cell surface proteomics revealed CD72 as an optimal target for poor-prognosis KMT2A/MLL1-rearranged (MLLr) B-cell acute lymphobla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4eda55a5274e3677f255a2fad22066d9
https://doi.org/10.1158/2159-8290.c.6548995.v1
https://doi.org/10.1158/2159-8290.c.6548995.v1
Autor:
Arun P. Wiita, Elliot Stieglitz, Aashish Manglik, Ansuman T. Satpathy, Byron C. Hann, Faranak Fattahi, Veronica Steri, Paul Phojanokong, Anne Deucher, Jonathan Ramirez, Kevin R. Parker, Sagar P. Bapat, Jeffrey D. Whitman, Kristie L. White, Makeba Marcoulis, Jose M. Rivera, Yu-Hsiu T. Lin, Neha Paranjape, Huimin Geng, Kamal Mandal, Matthew A. Nix
Supplementary Data from Surface Proteomics Reveals CD72 as a Target for In Vitro–Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::071cd4a9ceee3e0f3be7d0956260a267
https://doi.org/10.1158/2159-8290.22539136.v1
https://doi.org/10.1158/2159-8290.22539136.v1
Autor:
Arun P. Wiita, Elliot Stieglitz, Aashish Manglik, Ansuman T. Satpathy, Byron C. Hann, Faranak Fattahi, Veronica Steri, Paul Phojanokong, Anne Deucher, Jonathan Ramirez, Kevin R. Parker, Sagar P. Bapat, Jeffrey D. Whitman, Kristie L. White, Makeba Marcoulis, Jose M. Rivera, Yu-Hsiu T. Lin, Neha Paranjape, Huimin Geng, Kamal Mandal, Matthew A. Nix
Supplementary Figure from Surface Proteomics Reveals CD72 as a Target for In Vitro–Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02d17db5e546d5631791798d1c469ce4
https://doi.org/10.1158/2159-8290.22539127
https://doi.org/10.1158/2159-8290.22539127
Autor:
Bin Liu, Thomas G. Martin, Jeffery L. Wolf, Byron C. Hann, Shelby C. Bearrows, Megan Murnane, Olivia Perez de Acha, Blake T. Aftab, Christopher R. Behrens, Yang Su, Daniel W. Sherbenou
Purpose:New therapies have changed the outlook for patients with multiple myeloma, but novel agents are needed for patients who are refractory or relapsed on currently approved drug classes. Novel targets other than CD38 and BCMA are needed for new i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2337ae02925e53951af015e1c8c7900
https://doi.org/10.1158/1078-0432.c.6529680
https://doi.org/10.1158/1078-0432.c.6529680
Autor:
Bin Liu, Thomas G. Martin, Jeffery L. Wolf, Byron C. Hann, Shelby C. Bearrows, Megan Murnane, Olivia Perez de Acha, Blake T. Aftab, Christopher R. Behrens, Yang Su, Daniel W. Sherbenou
Supplementary Tables and Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84754db983525d7b500f261edbcffa82
https://doi.org/10.1158/1078-0432.22477488
https://doi.org/10.1158/1078-0432.22477488
Autor:
Charles S. Craik, Byron C. Hann, James D. Marks, Christopher J. Farady, Paul J. Phojanakong, Jianlong Lou, Eric L. Schneider, Molly R. Darragh
Supplementary Figure 4 from Tumor Detection by Imaging Proteolytic Activity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48840cf50c26f0a84ae789161a92f4f8
https://doi.org/10.1158/0008-5472.22386572
https://doi.org/10.1158/0008-5472.22386572
Autor:
Charles S. Craik, Byron C. Hann, James D. Marks, Christopher J. Farady, Paul J. Phojanakong, Jianlong Lou, Eric L. Schneider, Molly R. Darragh
Supplementary Figure 2 from Tumor Detection by Imaging Proteolytic Activity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d333cbf685b218f0922b1f6ef2b21c1
https://doi.org/10.1158/0008-5472.22386578.v1
https://doi.org/10.1158/0008-5472.22386578.v1
Autor:
Charles S. Craik, Byron C. Hann, James D. Marks, Christopher J. Farady, Paul J. Phojanakong, Jianlong Lou, Eric L. Schneider, Molly R. Darragh
Supplementary Figure 1 from Tumor Detection by Imaging Proteolytic Activity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5475715bde4fb5a501ff071109d487bd
https://doi.org/10.1158/0008-5472.22386581.v1
https://doi.org/10.1158/0008-5472.22386581.v1
Autor:
Charles S. Craik, Byron C. Hann, James D. Marks, Christopher J. Farady, Paul J. Phojanakong, Jianlong Lou, Eric L. Schneider, Molly R. Darragh
The cell surface protease membrane-type serine protease-1 (MT-SP1), also known as matriptase, is often upregulated in epithelial cancers. We hypothesized that dysregulation of MT-SP1 with regard to its cognate inhibitor hepatocyte growth factor activ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1807888727f30a3cefa6c3ce9ddf2fa
https://doi.org/10.1158/0008-5472.c.6501575
https://doi.org/10.1158/0008-5472.c.6501575